Whitepaper: Disinfectant Efficacy in cGMP-Compliant Pharmaceutical Manufacturing Settings

[Article Title]

The FDA’s intensified onsite inspections of drug production post-pandemic have underscored the importance of robust cleaning- and disinfectant-validation programs. This whitepaper focuses on the importance of disinfectant validations based on real-world conditions to maintain cGMP compliance. It discusses the current lack of specific testing requirements and limitations of current testing methods and emphasizes the growing importance of site-specific surface testing.

Download Document

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

  • Question 1
    Question 2

  • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.